MedTrace Logo

Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids

NCT01913158 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-11-03

No results posted yet for this study

Summary

The primary objective of this study is to determine the safety and efficacy of G\&W Laboratories' Anucort HC TM (Hydrocortisone Acetate) 25mg Rectal Suppositories in subjects with internal hemorrhoidal symptoms.

Conditions

  • Internal Hemorrhoids

Interventions

DRUG

Anucort-HC, 25 Mg Rectal Suppository

Hydrocortisone acetate suppositories

DRUG

Placebo suppository

Hydrogenated palm kernel oil suppositories

Sponsors & Collaborators

  • G & W Laboratories Inc.

    lead INDUSTRY

Principal Investigators

  • Allan G Coates, DO · Gastro Associates of Western Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01913158 on ClinicalTrials.gov